Medicinal Chemistry

Medicinal chemistry is the cornerstone of HIT2IND MedChem Consulting, helping you at any stage from Hit ID through Lead Optimization.

6

Clinical Development Candidates

1 Approved Drug, 1 Phase 2 Compound, 4 Phase 1 Compounds.

6

Therapeutic Areas

Rare Diseases, Antibacterials, Inflammation, Obesity, Diabetes, Oncology.

>15

Disease Targets

Kinases, GPCRs, Nuclear Hormone Receptors, Prokaryotic and Eukaryotic Ribosomes, Ion Channels.

Hit ID and Generation

Whether you have your own compound library to screen or need to generate new hits, we can help identify the best methods and sort through the data.

Hit-to-Lead and Lead Optimization

Establishing SAR and optimizing key properties (potency, selectivity, ADME, physicochemical properties, etc.) to rapidly establish proof of concept in relevant in vitro and in vivo disease models and move your program to a preclinical candidate.

IP Strategy

We work with chemistry teams and patent attorneys to create IP strategy and ensure maximum protection for your projects.